Development of a cost-effectiveness analysis model for Duchenne muscular dystrophy utilizing the national registry in Japan. [PDF]
Okada T +5 more
europepmc +1 more source
256. An Ideal Therapeutic Agent for Duchenne Muscular Dystrophy Involving a Gutted Adenovirus Expressing Full-Length Utrophin [PDF]
openalex +1 more source
Diagnostic Precision in Pediatric Neuromuscular Disorders: A Case Study of Bethlem Myopathy Mimicking Duchenne Muscular Dystrophy. [PDF]
Alyami NH +5 more
europepmc +1 more source
Exploring the evidence for the use of protein biomarkers of muscular damage and disease progression in Duchenne and Becker muscular dystrophy: a systematic review and meta-analysis protocol. [PDF]
Mondello S +7 more
europepmc +1 more source
Longitudinal
Claudia Godi +19 more
openalex +1 more source
Sleep Disordered Breathing and Its Predictors in Pediatric Muscular Dystrophies. [PDF]
Abu Zahra M +3 more
europepmc +1 more source
Multiparametric cardiac magnetic resonance evaluation of myocardial involvement in Duchenne muscular dystrophy: A case report. [PDF]
Takamure H +8 more
europepmc +1 more source

